Cargando…

Gerosuppressant Metformin: less is more

Detalles Bibliográficos
Autores principales:	Menendez, Javier A., Cufí, Sílvia, Oliveras-Ferraros, Cristina, Vellon, Luciano, Joven, Jorge, Vazquez-Martin, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2011
Materias:	Commentaries and Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117449/ https://www.ncbi.nlm.nih.gov/pubmed/21483040

Ejemplares similares

Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
por: Menendez, Javier A., et al.
Publicado: (2011)

One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin
por: Menendez, Javier A., et al.
Publicado: (2013)

Metformin: Multi-faceted protection against cancer
por: Del Barco, Sonia, et al.
Publicado: (2011)

Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
por: Corominas-Faja, Bruna, et al.
Publicado: (2012)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
por: Cufí, Sílvia, et al.
Publicado: (2013)

Metformin-induced preferential killing of breast cancer initiating CD44(+)CD24(−/low) cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
por: Cufí, Sílvia, et al.
Publicado: (2012)

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment
por: Cufí, Sílvia, et al.
Publicado: (2012)

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
por: Oliveras-Ferraros, Cristina, et al.
Publicado: (2011)

Gerosuppression in confluent cells
por: Leontieva, Olga V., et al.
Publicado: (2014)

Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2009)

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
por: Cufí, Sílvia, et al.
Publicado: (2013)

Gerosuppression by pan-mTOR inhibitors
por: Leontieva, Olga V., et al.
Publicado: (2016)

Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection
por: Aragonès, Gerard, et al.
Publicado: (2010)

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)

The Hormetic Effect of Metformin: “Less Is More”?
por: Panfoli, Isabella, et al.
Publicado: (2021)

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells
por: Oliveras-Ferraros, C, et al.
Publicado: (2012)

Metformin and cancer: Quo vadis et cui bono?
por: Menendez, Javier A., et al.
Publicado: (2016)

IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2013)

Minimally invasive carinal reconstruction—is less really more?
por: Frick, Anna Elisabeth, et al.
Publicado: (2021)

Rejuvenating regeneration: Metformin activates endogenous adult stem cells
por: Menendez, Javier A., et al.
Publicado: (2012)

Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay
por: Matic, Ivana, et al.
Publicado: (2016)

Commentary: When is less more?
por: Sinha, Pranava
Publicado: (2021)

tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)
por: Menendez, Javier A, et al.
Publicado: (2008)

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics
por: Puig-Costa, Manuel, et al.
Publicado: (2014)

Commentary: More haste, less speed
por: Weltert, Luca Paolo, et al.
Publicado: (2020)

Commentary: In the hands of the few, less is more
por: Vervoort, Dominique, et al.
Publicado: (2021)

Commentary: Less is more in thoracic surgery
por: Okado, Shoji, et al.
Publicado: (2022)

Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Molecular systems biology at the crossroads: to know less about more, or to know more about less?
por: Latterich, Martin
Publicado: (2005)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Less Is More: Burkholderia pseudomallei and Chronic Melioidosis
por: Nandi, Tannistha, et al.
Publicado: (2013)

COVID-19: When more might be less
por: Mugnai, Giacomo, et al.
Publicado: (2021)

Commentary: Right ventriculotomy: Less is still more
por: Bichell, David P.
Publicado: (2021)

Is LESS is actually more?
por: Kekre, Nitin S.
Publicado: (2012)

Less is not always more
por: Batlle Solà, M., et al.
Publicado: (2022)

More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes
por: Shallis, Rory M., et al.
Publicado: (2018)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Oropharyngeal decontamination in intensive care patients: less is not more
por: Derde, Lennie PG, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0m5bkpn8bgde7bneklvnu7veso